COMMUNIQUÉS West-GlobeNewswire

ClinNEXUS Appoints John Stamatopoulos to New Position of Chief Growth Officer
04/08/2026
- Seasoned digital health growth executive with demonstrated ability to build revenue and drive disciplined expansion - LOS ANGELES, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ClinNEXUS, a data-driven healthcare company that’s [...]
FSR Invests $700,000 Across Four Sarcoidosis Studies to Improve Diagnosis, Monitoring, and Patient Outcomes
04/08/2026
CHICAGO, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) has awarded $700,000 in grant funding to four awardees through its Early Career Fellowship and Established Investigator grant [...]
Taysha Gene Therapies to Release Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 11
04/08/2026
DALLAS, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies [...]
Pennant Acquires River Centre Assisted Living in Tucson, Arizona
04/08/2026
EAGLE, Idaho, Aug. 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of Pennant affiliated home health, hospice, home care and senior living companies, announces today that [...]
Applied Biologics Marks 10 Years of Continuous AATB Accreditation While Initiating Reaccreditation Process
04/08/2026
Company continues its longstanding commitment to quality, safety, and regulatory excellence supporting the manufacture and distribution of XWRAP® SCOTTSDALE, Ariz., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a [...]
Acquisition of Own Shares
04/08/2026
Mechelen, Belgium; 04 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]
Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026
04/08/2026
CAMBRIDGE, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, [...]
Syndax Reports Second Quarter 2026 Financial Results and Provides Business Update
04/08/2026
– Total revenue of $73 million in 2Q26, a 92% year-over-year increase – – Revuforj ® (revumenib) net revenue of $54.7 million in 2Q26, a 91% year-over-year increase – – Niktimvo™ (axatilimab-csfr) net revenue of $60.3 [...]
Milestone Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 12, 2026
04/08/2026
MONTREAL and CHARLOTTE, N.C., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/08/2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that [...]
Pacira BioSciences Reports Second Quarter 2026 Financial Results
04/08/2026
-- Continued execution of 5x30 strategy marked by solid revenue growth, durable cashflows, advancing pipeline, and high-caliber commercial partnerships -- -- Delivered second quarter total revenue of $192.4 million, [...]
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results
04/08/2026
Advancing a neuromuscular franchise with claseprubart, a highly potent investigational classical pathway inhibitor, with best-in-disease potential across generalized Myasthenia Gravis (gMG), Chronic Inflammatory [...]
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
04/08/2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
04/08/2026
Announced positive topline induction data for SPY001 and SPY002 from Part A of the Phase 2 SKYLINE trial (“SKYLINE”), demonstrating best-in-class efficacy potential and a safety profile consistent with in-class [...]
Ultragenyx Reports Second Quarter 2026 Financial Results and Corporate Update
04/08/2026
Second quarter total revenue of $214 million, Crysvita ® revenue of $156 million and Dojolvi ® revenue of $27 million Reaffirm 2026 financial guidance, including total revenue of $730 million to $760 million and [...]
Sienna Forms Joint Venture With Fiera Infrastructure to Expedite Long-Term Care Redevelopments
04/08/2026
MARKHAM, Ontario, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it has formed a joint venture relationship with Fiera Infrastructure Inc. (“ [...]
OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance
04/08/2026
Second Quarter 2026 Revenue Surpasses $70 million for the First Time in Company History, and Increased 15% Year-over-Year WARSAW, Ind., Aug. 04, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “ [...]
Amwell® Announces Results for the Second Quarter 2026
04/08/2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended [...]
PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results
04/08/2026
SAN JOSE, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions [...]

Pages